LIGAND PHARMACEUTICALS INC Insider Trading for February 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LIGAND PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LIGAND PHARMACEUTICALS INC for February 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 2018 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 155.00 | 3,417 | 529,635 | 86,834 | 90.3 K to 86.8 K (-3.79 %) |
| Feb 27 2018 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Gift | G | 0.00 | 1,000 | 0 | 58,625 | 59.6 K to 58.6 K (-1.68 %) |
| Feb 27 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Sell | S | 151.90 | 12,335 | 1,873,709 | 53,563 | 65.9 K to 53.6 K (-18.72 %) |
| Feb 27 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Sell | S | 153.58 | 4,835 | 742,536 | 65,898 | 70.7 K to 65.9 K (-6.84 %) |
| Feb 27 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 14.47 | 5,444 | 78,775 | 54,556 | |
| Feb 27 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 9.97 | 1,004 | 10,010 | 42,081 | |
| Feb 27 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Sell | S | 152.98 | 5,444 | 832,824 | 95,835 | 101.3 K to 95.8 K (-5.38 %) |
| Feb 27 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 14.47 | 5,444 | 78,775 | 101,279 | 95.8 K to 101.3 K (+5.68 %) |
| Feb 27 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 9.97 | 1,004 | 10,010 | 95,835 | 94.8 K to 95.8 K (+1.06 %) |
| Feb 16 2018 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Payment of Exercise | F | 157.18 | 260 | 40,867 | 25,059 | 25.3 K to 25.1 K (-1.03 %) |
| Feb 16 2018 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Payment of Exercise | F | 157.18 | 252 | 39,609 | 25,319 | 25.6 K to 25.3 K (-0.99 %) |
| Feb 16 2018 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Payment of Exercise | F | 157.18 | 524 | 82,362 | 25,571 | 26.1 K to 25.6 K (-2.01 %) |
| Feb 16 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 157.18 | 1,246 | 195,846 | 94,831 | 96.1 K to 94.8 K (-1.30 %) |
| Feb 16 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 157.18 | 906 | 142,405 | 96,077 | 97 K to 96.1 K (-0.93 %) |
| Feb 16 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 157.18 | 1,511 | 237,499 | 96,983 | 98.5 K to 97 K (-1.53 %) |
| Feb 16 2018 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Payment of Exercise | F | 157.18 | 1,689 | 265,477 | 96,458 | 98.1 K to 96.5 K (-1.72 %) |
| Feb 16 2018 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Payment of Exercise | F | 157.18 | 1,918 | 301,471 | 98,147 | 100.1 K to 98.1 K (-1.92 %) |
| Feb 16 2018 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Payment of Exercise | F | 157.18 | 2,635 | 414,169 | 100,065 | 102.7 K to 100.1 K (-2.57 %) |
| Feb 16 2018 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Sell | S | 157.03 | 9,000 | 1,413,279 | 102,700 | 111.7 K to 102.7 K (-8.06 %) |
| Feb 16 2018 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Payment of Exercise | F | 157.18 | 326 | 51,241 | 9,687 | 10 K to 9.7 K (-3.26 %) |
| Feb 16 2018 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Payment of Exercise | F | 157.18 | 354 | 55,642 | 10,013 | 10.4 K to 10 K (-3.41 %) |